医学
疾病
重症监护医学
叙述性评论
死因
医疗保健系统
医疗保健
内科学
经济
经济增长
作者
Ben Barris,Avrohom Karp,Menachem Jacobs,William H. Frishman
标识
DOI:10.1097/crd.0000000000000892
摘要
Cardiovascular disease (CVD) has remained the leading cause of death among adults for more than one hundred years. With persistently suboptimal outcomes and a profound economic burden on our healthcare system, there is growing interest in alternative treatment approaches for CVD. One such approach is Tongxinluo (TXL) capsules, a Traditional Chinese Medicine (TCM). TXL is commonly used in China and offers a potentially safe, efficacious, and cost-effective treatment option. To address the limited awareness of TXL in the United States, this narrative review will provide a broad overview of its composition, pharmacological mechanisms, and clinical applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI